Harvard Bioscience Q3 2026 Earnings Preview
- Harvard Bioscience (HBIO) is scheduled to announce Q3 earnings results on Tuesday, November 10th, before market open.
- The consensus EPS Estimate is -$0.17 (-466.7% Y/Y) and the consensus Revenue Estimate is $21.8M (+5.8% Y/Y).
- Over the last 2 years, HBIO
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.